SEC23A and colorectal carcinoma: Furthermore, significantly diminished SEC23A expression levels were discerned in established CRC PDX models of 5-FU-pretreated metastatic CRC lesions when directly compared to primaries from the same patients, as well as in 5-FU-resistant cell lines.